Connect with us


Sensex falls over 500 points after touching fresh high, Nifty below 13K



The Indian equity indices slumped from the record highs on Wednesday afternoon.

The BSE Sensex declined over 500 points to fall below the psychological mark of 44,000 and the Nifty50 dropped below 13,000.


The across-the-board selling was led by banking, finance, IT, telecom and capital goods stocks.

Around 2.40 p.m., Sensex was at 43,948.26, lower by 574.76 points or 1.29 per cent from the previous close of 44,523.02.

Earlier in the day it had touched an all-time high of 44,825.37 points. It had opened at 44,749.73 and has so far touched an intra-day low of 43,845.86 points.

The Nifty50 on the National Stock Exchange was had hit an all-time high of 13,145.85, is currently trading at 12,900.40, lower by 154.75 points or 1.19 per cent from its previous close.

Continue Reading


447 cases of adverse effect reported,Covid-19 vaccine given to 2,24,301 beneficiaries :Govt.



A total of 2,24,301 beneficiaries have been inoculated with COVID-19 vaccine so far, out of which only 447 adverse events following immunisation (AEFI) were reported, the Union Health Ministry said on day two of the nationwide vaccination drive on Sunday.

Addressing a press briefing, the ministry’s Additional Secretary Manohar Agnani said out of the 447 adverse events following immunisation, only three required hospitalisation.

“Today being Sunday, only six states conducted vaccination drive and in 553 sessions a total of 17,072 beneficiaries were vaccinated,” he said.

The six states where the vaccination drive was carried out on Sunday are Andhra Pradesh, Arunachal Pradesh, Karnataka, Kerala, Manipur and Tamil Nadu, he added.

Agnani said a total of 2,24,301 beneficiaries have been vaccinated till January 17 as per provisional reports, adding that 2,07,229 of them received the jabs on day one of the drive.

“A total of 447 AEFI have been reported on January 16 and 17, out of which only three required hospitalisation. Most of the AEFI reported so far are minor like fever, headache, nausea,” he said.

He said a meeting was held with all states and union territories on Sunday to review the progress of the drive, identify bottlenecks and plan corrective actions.

Prime Minister Narendra Modi rolled out the world’s largest inoculation drive against COVID-19 on Saturday and said the two vaccines being deployed will ensure a “decisive victory” for India against the pandemic.

India has approved two vaccines—Covaxin developed by Bharat Biotech and Covishield from the Oxford/AstraZeneca stable being manufactured by the Serum Institute of India—for emergency use in the country.

According to the government, the shots will be offered first to an estimated one crore healthcare workers and around two coror frontline workers, and then to persons above 50 years of age, followed by persons younger than 50 years of age with associated comorbidities. PTI

Continue Reading